Kelly Martin News
Most Popular Kelly Martin Story
Investors revolt to block Elan sale
Investors at Elan aren't going to take it anymore. They're stepping up to block the sale of a stake in the company to a "large pharmaceuticals partner," the Financial Times reports. And they're... Read more...
Latest Headlines
- June 12, 2009
- February 9, 2009
- December 22, 2008
- December 15, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
